A PHA-producing engineered halomonas and a method for producing PHA
By regulating the expression of the cytochrome d oxidase complex gene cydA, the problem of dissolved oxygen demand in the later stage of fermentation of Saltmonas is solved, and efficient PHA synthesis is achieved under hypoxia or anaerobic conditions, which improves yield and reduces energy consumption , provides low-cost industrial production solutions.
Patent Information
- Application Number
- CN202410996358.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-24
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2044-07-24
AI Technical Summary
During the PHA fermentation process of Saltmonas, high speeds are still needed to maintain a high dissolved oxygen level in the later stage of fermentation, resulting in excessive oxidation pressure and waste of energy. Low speed or stopping stirring will inhibit PHA synthesis and reduce yield.
By regulating the expression or encoding protein activity of the cytochrome d oxidase complex gene cydA, the dissolved oxygen requirement of Saltmonas spp. in the late fermentation stage is reduced, so that it can still efficiently synthesize PHA under hypoxia or anaerobic conditions.
It realizes efficient PHA synthesis under low speed or even no stirring conditions in the later stage of fermentation, significantly improves PHA production, reduces the energy consumption of the fermentation process, and provides a low-cost and low-energy-consuming solution for industrial production.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] The present invention relates to the field of microbial technology, and in particular to an engineered halomonas producing PHA and a method for producing PHA. Background Art
[0002] Halomonas Halomonas sp. ) is a type of moderate halophilic bacteria isolated from Xinjiang Aidin Salt Lake. Its optimal growth salt concentration is 6%, the optimal growth pH is 9.0, and it consumes a large amount of glucose to synthesize the dominant product PHA during its growth.
[0003] Microbial growth often requires a certain supply of oxygen to maintain normal cell activity. When ventilation alone cannot meet the bacterial oxygen demand, the fermentation broth needs to be stirred to further increase the dissolved oxygen in the culture medium. In the fermentation process of synthesizing PHA using Halomonas, the overall process is divided into two stages: the first stage is mainly cell proliferation and growth, and the cell oxygen demand is relatively high in this stage; the second stage is mainly the cell catalyzing the substrate glucose to synthesize PHA. In theory, this process does not require the participation of oxygen, but in practice, if the air supply is stopped at this stage, the PHA production will be seriously impaired. Therefore, the current fermentation method usually increases the rotation speed from 400rpm to 800rpm at a uniform speed during the 0-16 hours of the fermentation cycle, that is, the cell accumulation stage, and maintains the rotation speed at 800rpm until the end of fermentation.
[0004] However, since PHA synthesis in the later stage of fermentation theoretically does not require oxygen consumption, maintaining a high speed in the later stage may provide excessive oxygen, which may lead to excessive oxidative stress on the microorganisms and cause metabolic disorders, while greatly increasing energy consumption and causing energy waste; however, if the speed is low or stirring is stopped, PHA synthesis will be inhibited, resulting in a decrease in the final yield. Summary of the invention
[0005] The present invention provides an engineered halomonas producing PHA and a method for producing PHA.
[0006] In order to solve the problem that Halomonas still needs to maintain a high rotation speed to maintain a high dissolved oxygen level in the late fermentation stage (i.e., the PHA synthesis stage) during the PHA fermentation production process, the present invention attempts to engineer Halomonas to uncouple the late fermentation stage from the dissolved oxygen demand. The present invention found that regulating the cytochrome d oxidase complex gene co The expression of or the activity of its encoded protein will affect the dissolved oxygen demand of Halomonas in the late fermentation period and reduce the expression of cytochrome d oxidase complex gene co The expression of or the activity of its encoded protein can significantly reduce the dissolved oxygen demand of Halomonas in the late fermentation stage, thereby achieving efficient synthesis of PHA under low rotation speed or even no stirring conditions in the late fermentation stage.
[0007] Specifically, the present invention provides the technical solution described below.
[0008] In a first aspect, the present invention provides a cytochrome d oxidase complex gene co Application of reducing the expression level and / or the activity of its encoded protein in improving the PHA production performance of Halomonas;
[0009] The improving the PHA production performance of Halomonas is to improve the PHA production performance of Halomonas under anoxic or anaerobic conditions in the late fermentation period.
[0010] Cytochrome d oxidase complex gene co The reduction of the expression level and / or the activity of its encoded protein will affect the cell growth state, especially, co After inactivation, Halomonas no longer releases a large amount of reducing hydrogen when synthesizing PHA. Therefore, the cells can continue to generate reducing power and accumulate PHA in large quantities under conditions of hypoxia or no oxygen supply but with sufficient nutrients (nitrogen source, etc.). At this time, oxygen supply is no longer a limiting factor for PHA synthesis.
[0011] Based on the technical problems to be solved by the present invention, the improvement of the PHA production performance is aimed at the following conditions: the late stage of the fermentation of PHA by Halomonas fermentation is in anoxic or anaerobic state; and the conventional normal dissolved oxygen level can be used in the early stage of fermentation to meet the needs of cell growth.
[0012] In the present invention, the process of producing PHA by fermentation of Halomonas is divided into two stages: the early fermentation stage, i.e., the cell growth stage, and the late fermentation stage, i.e., the PHA synthesis stage; wherein, the early fermentation stage refers to the period from the start of fermentation to the plateau period of cell growth, and the late fermentation stage refers to the period from the plateau period of cell growth to the end of fermentation. The time when cells enter the late fermentation stage will vary depending on the fermentation process conditions (such as the nitrogen source content in the initial culture medium, the stirring rate, the dissolved oxygen content, etc.), but those skilled in the art can clearly judge the arrival of the late fermentation stage based on the cell growth curve. Taking the entire fermentation cycle of 36-48 hours as an example, the time to enter the late fermentation stage is generally 12 hours to 18 hours, and usually enters the late fermentation stage after 16 hours.
[0013] Preferably, the late fermentation stage is judged as follows: the specific growth rate μ of the net cell biomass is less than 0.01.
[0014] For Halomonas, the anoxic or anaerobic state in the late fermentation period means that the dissolved oxygen level in the late fermentation period is not higher than 10%.
[0015] In some specific embodiments of the present invention, the anoxic or anaerobic condition is that the stirring speed is not higher than 400 rpm.
[0016] The above mentioned co The nucleotide sequence of a gene and the amino acid sequence of its encoded protein can be obtained through public databases. co The nucleotide sequence of the gene is shown in SEQ ID NO.1.
[0017] The cytochrome d oxidase complex described above has an amino acid sequence encoded by the nucleotide sequence shown in SEQ ID NO.1.
[0018] In the present invention, for realizing co There is no particular limitation on the technical means for reducing the expression level of a gene and / or the activity of its encoded protein. For example, the gene, its encoded protein, its regulatory element or regulatory protein can be modified by commonly used genetic engineering means and gene editing methods to make co The expression level and / or the activity of its encoded protein is reduced.
[0019] Exemplarily, the reduction in the expression level of the gene and / or the activity of its encoded protein is achieved by a combination of any one or more of the following (1) to (3):
[0020] (1) Mutate the amino acid sequence of the protein;
[0021] (2) Mutating the nucleotide sequence of a gene;
[0022] (3) Replace the transcriptional and / or translational regulatory elements of the gene with elements with weaker activity.
[0023] The mutation of the amino acid sequence described above includes deletion, insertion or substitution of one or more amino acids.
[0024] The mutation of the nucleotide sequence described above includes deletion, insertion or substitution of one or more nucleotides.
[0025] The transcription and translation regulatory elements mentioned above include promoters, ribosome binding sites, etc.
[0026] Preferably, the cytochrome d oxidase complex gene co The expression level and / or activity of its encoded protein is reduced by inactivating the cytochrome d oxidase complex gene co accomplish.
[0027] In some embodiments of the invention, the inactivation is a knockout.
[0028] In the above applications, Halomonas ( Halomonas ) including Halomonas ( Halomonas bluephagenesis ) or Halomonas ( Halomonas campaniensis ).
[0029] In the present invention, the PHA production performance includes PHA yield, PHA proportion in cells, PHA production intensity, PHA conversion rate, etc.
[0030] In a second aspect, the present invention provides a cytochrome d oxidase complex gene co The application of reducing the expression level and / or the activity of its encoded protein in breeding Halomonas suitable for fermentation and production of PHA under anaerobic or anaerobic conditions in the late fermentation period.
[0031] The above-mentioned PHA-producing Halomonas can be selected and bred by genetic engineering, mutagenesis, adaptive evolution and other methods.
[0032] The above-mentioned Halomonas suitable for producing PHA under anaerobic or anoxic conditions in the late fermentation period refers to a production bacterium with significantly improved yield of PHA produced under anaerobic or anoxic conditions in the late fermentation period.
[0033] Preferably, Halomonas ( Halomonas ) including Halomonas ( Halomonas bluephagenesis ) or Halomonas ( Halomonas campaniensis ).
[0034] In a third aspect, the present invention provides an engineered Halomonas bacteria that produces PHA, wherein the cytochrome d oxidase complex gene in the Halomonas bacteria is co The expression level and / or the activity of its encoded protein is reduced.
[0035] Preferably, in the Halomonas, the cytochrome d oxidase complex gene co Inactivation.
[0036] In the present invention, the gene inactivation can be achieved by inserting, deleting or replacing one or more nucleotides in the gene.
[0037] Preferably, the PHA production performance of the engineered Halomonas under anaerobic or anoxic conditions in the late fermentation period is improved due to the reduced expression level of the cytochrome d oxidase complex gene cydA and / or the activity of its encoded protein.
[0038] Preferably, the Halomonas includes Halomonas ( Halomonas bluephagenesis ) or Halomonas ( Halomonas campaniensis ).
[0039] The present invention has no particular limitation on the starting strain of the engineered Halomonas for producing PHA, and can be any strain having the ability to synthesize PHA and containing the cytochrome d oxidase complex gene. co Halomonas. The present invention has verified the cytochrome d oxidase complex gene by testing it in multiple strains of Halomonas. coThe transformation strategy of reducing the expression level and / or the activity of its encoded protein is universal in Halomonas and does not depend on the specific genetic background of the starting strain; by reducing the expression level of the cytochrome d oxidase complex gene co The expression level and / or activity of its encoded protein were significantly increased in the fermentation of different Halomonas under anoxic or anaerobic conditions in the late fermentation period.
[0040] The cytochrome d oxidase complex described above has an amino acid sequence encoded by the nucleotide sequence shown in SEQ ID NO.1.
[0041] In a fourth aspect, the present invention provides a method for constructing the engineered Halomonas producing PHA as described above, the method comprising: modifying Halomonas so that the cytochrome d oxidase complex gene co The expression level and / or the activity of its encoded protein is reduced.
[0042] In a fifth aspect, the present invention provides the use of the engineered PHA-producing Halomonas described above in PHA production or breeding of PHA-producing bacteria.
[0043] The above-mentioned production bacteria can be selected and bred by genetic engineering, mutagenesis, adaptive evolution and other methods.
[0044] In a sixth aspect, the present invention provides a method for producing PHA, comprising: fermenting and culturing the engineered Halomonas producing PHA described above, and collecting PHA in the culture.
[0045] In the above method, the fermentation culture includes an early fermentation period and a late fermentation period; in the early fermentation period, the dissolved oxygen is maintained at not less than 30% (preferably 30%-50%), and in the late fermentation period, the dissolved oxygen is maintained at not more than 10%.
[0046] Preferably, aeration and stirring are performed in the early stage of fermentation, and stirring is stopped in the late stage of fermentation.
[0047] Preferably, stirring is stopped after the specific growth rate μ of the net cell biomass is <0.01.
[0048] Preferably, stirring is stopped in the late fermentation stage and ventilation is maintained in the early fermentation stage.
[0049] Preferably, the stirring speed in the early stage of fermentation is 400-800 rpm. The ventilation volume in the early stage of fermentation is 0.5-1.5 vvm.
[0050] Preferably, the fermentation culture uses carbohydrates as carbon sources. The culture medium used in the fermentation culture also contains 5-100 g / L sodium chloride; the role of adding sodium chloride is mainly to provide the osmotic pressure environment required for the growth of halophilic bacteria.
[0051] Preferably, the temperature of the fermentation culture is 35-37° C. The pH of the fermentation culture is 8.5-9.0.
[0052] The main advantage of using halophilic bacteria to produce PHA is that it can be fermented in an open environment without additional sterilization. At the same time, it does not require the use of various air filters and complex aseptic operations to reduce the possibility of contamination during the fermentation process, which greatly saves production costs and manpower and material resources. Conventional open fermentation of halophilic bacteria relies on a high-salt and high-pH environment to inhibit the growth of other bacteria.
[0053] Preferably, the culture medium used in the fermentation culture comprises the following components: 10-30 g / L glucose, 5-15 g / L sodium chloride, 0.4-0.7 g / L urea, 0.1-0.3 g / L MgSO4, 1.3-1.7 g / L KH2PO4, and 0.03-0.07 g / L Fe(III)-NH4-Citrate, 0.01-0.04 g / L CaCl2·2H2O, 0.08-0.2 mg / L ZnSO4·7H2O, 0.02-0.04 mg / L MnCl2·4H2O, 0.2-0.4 mg / L H3BO3, 0.1-0.3 mg / L CoCl2·6H2O, 0.008-0.015 mg / L CuSO4·5H2O, 0.01-0.03 mg / L NiCl2·6H2O, 0.02-0.04mg / L NaMoO4·2H2O.
[0054] The beneficial effects of the present invention include at least: the present invention finds that reducing the cytochrome d oxidase complex gene co The expression level or activity of its encoded protein can significantly reduce the demand for dissolved oxygen of Halomonas in the late fermentation period, so that the strain can still efficiently synthesize PHA under anoxic or anaerobic conditions with low speed or even no stirring in the late fermentation period, thereby effectively increasing the yield of PHA. The engineered Halomonas provided by the present invention significantly improves the yield of PHA under anoxic or anaerobic conditions with low speed or even no stirring in the late fermentation period, and can achieve a high yield of PHA under no stirring conditions in the late fermentation period, which is beneficial to reducing energy consumption in the fermentation process, and provides an effective solution for realizing low-cost and low-energy industrial production of PHA. DETAILED DESCRIPTION
[0055] In order to make the purpose, technical solution and advantages of the present invention clearer, the technical solution of the present invention will be described clearly and completely below. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0056] Unless otherwise specified, the materials and reagents used in the following examples can be obtained from commercial sources.
[0057] The following examples used Halomonas ( Halomonas bluephagenesis TD01 was deposited in the General Microbiological Center of China Microbiological Culture Collection Administration on November 19, 2010, with the deposit registration number of CGMCC No.4353 and the classification name of Halomonas Halomonas sp. TD01 (also known as Halomonas bluephagogenesis TD01), which is recorded in patent application CN102120973A and can be obtained from Tsinghua University. Halomonas campaniensis LS21 is a Gram-negative halophilic bacterium obtained in the early screening. It was deposited in the General Microbiological Center of China Microbiological Culture Collection Administration on September 20, 2012, with the deposit number CGMCC No.6593, and was classified as Halomonas ( Halomonas sp. ) (also called Halomonas ( Halomonas campaniensis )LS21), which has very good prospects for industrial production and application, has been disclosed in patent application CN102925382A and the public can obtain this strain from Tsinghua University. Halomonas bluephagenesis ) WZY254, see the literature (Ji, M., et al. PHB production from food waste hydrolysates by Halomonas bluephagenesis harboring PHB operon linked with an essential gene. Metabolic Engineering, 2023, 77, 12-20.), the public can obtain this strain from Tsinghua University.
[0058] In the following examples, the specific formula of the basal medium (MM) for culturing Halomonas is as follows: 0.5 g / L urea; 0.2 g / L MgSO4; 1.5 g / L KH2PO4; and 0.05 g / L Fe(III)-NH4-Citrate, 0.02 g / L CaCl2·2H2O, 0.1 mg / L ZnSO4·7H2O, 0.03 mg / L MnCl2·4H2O, 0.3 mg / L H3BO3, 0.2 mg / L CoCl2·6H2O, 0.01 mg / L CuSO4·5H2O, 0.02 mg / L NiCl2·6H2O, and 0.03 mg / L NaMoO4·2H2O.
[0059] In the following examples, the aforementioned MM medium was used as the basal medium and glucose and sodium chloride were added to carry out fermentation experiments in a fermenter. The fermenter used a 7L fermenter, the fermentation liquid volume was 3L, the pH was set at 9.0, and the temperature was maintained at 37°C. 20 g / L of glucose was added to the culture medium as a carbon source, and 10 g / L of sodium chloride was added to provide the osmotic pressure environment required for the growth of halophilic bacteria; and the pH was controlled to 9.0. In the early stage of fermentation, a dissolved oxygen stirring coupling setting was adopted, the ventilation volume was 0.5-1.5 vvm, and the speed slowly climbed from 400 rpm to 800 rpm. The dissolved oxygen was kept not less than 30% (preferably 30%-50%) during the process. Feeding was performed during the fermentation process to maintain the glucose in the fermentation system at about 10 g / L.
[0060] In the following examples, the content of polyhydroxyalkanoate (PHA) was detected by gas chromatography, and the method was as follows: the furnace temperature was set to 80°C, the injector temperature was 200°C, the detector temperature was 220°C, the column head pressure was 0.25Mpa, and the program temperature was as follows: stay at 80°C for 1.5 minutes, increase the temperature to 140°C at a rate of 30°C / min, and then increase the temperature to 220°C at a rate of 40°C / min and keep at this temperature for 0.5 minutes. The injection volume of the sample was 1 μL, and a microinjector produced by Agilent was used.
[0061] Sample preparation for gas chromatography detection: Take 40-60 mg of dry cells of the sample to be tested (take the bacterial solution and centrifuge it at 10000 rpm at room temperature for 10 minutes, wash the obtained cell precipitate with water once, and then vacuum freeze-dry to obtain dry cells. Homopolymers are produced in cells), add 2 mL of chloroform and 2 mL of esterification solution (pure methanol containing 3% (v / v) concentrated sulfuric acid and 1g / L benzoic acid as internal standard) in the esterification tube, cover and seal it, and heat it at 100°C for 4 hours. After cooling, add 1 mL of distilled water, shake it thoroughly and let it stand. After the chloroform phase and the water phase are completely separated, take 1 μL of the lower chloroform phase and inject it into the gas chromatograph (HP Hewlett Packard 6890) for chromatographic analysis. Operate the gas chromatograph according to the instructions of the HP Hewlett Packard 6890 gas chromatograph.
[0062] Preparation of standard samples for gas chromatography detection: Take 10-20 mg of standard sample in an esterification tube, add 2 mL of chloroform and 2 mL of esterification liquid, cover and seal, and then esterify at 100°C.
[0063] Result analysis: Taking the standard sample as the control, if the esterified sample of the cells to be tested (the sample to be tested) has an obvious peak at the standard sample, the mass of each monomer can be calculated according to the peak area, and then the molar ratio can be calculated according to the mass fraction of each monomer; the proportion of polymers in the dry weight of cells can be calculated according to the amount of sample added (wt%).
[0064] The bacterial biomass, i.e., dry cell weight (TCM, g / L) mentioned in the following examples is the ratio of the mass of the dry bacterial cells minus the mass of PHA therein to the volume of the fermentation broth at the end of the fermentation.
[0065] The PHA content (wt%) mentioned in the following examples is the mass ratio of PHA to the dry bacterial cells; the PHA yield is the ratio of the mass of PHA accumulated by the strain to the volume of the fermentation broth.
[0066] In the following examples, knockout co The genetic method can adopt the conventional method in the field of genetic engineering.
[0067] Embodiment 1, co Construction and fermentation experiments of gene knockout Halomonas (1)
[0068] Halomonas Halomonas bluephagenesis ) TD01 knockout co Gene, knocked out co The strain was named TD01ΔcydA.
[0069] The TD01ΔcydA strain was subjected to a fermentation tank fermentation experiment. In the late fermentation period (after the specific growth rate of net cell biomass μ < 0.01, i.e., 16 h after fermentation), stirring was turned off (the ventilation volume in the early fermentation period was maintained, and the dissolved oxygen level was controlled at no more than 10%) to carry out PHB synthesis, and the fermentation lasted for a total of 48 h. The TD01 strain was used as a control. At the same time, a control with normal stirring (800 rpm) was set up in the late fermentation period.
[0070] Compare co The PHB production of the strain before and after gene knockout under the control of the above-mentioned different fermentation processes is shown in Table 1.
[0071] Table 1
[0072]
[0073] The above results show that in Halomonas ( Halomonas bluephagenesis ) TD01 knockout co , higher PHB yields can be achieved under anoxic conditions when stirring is stopped in the late fermentation stage.
[0074] Embodiment 2, co Construction and fermentation experiments of gene knockout Halomonas (2)
[0075] Halomonas Halomonas campaniensis ) LS21 knockout co Gene, knocked out co The strain was named LS21ΔcydA.
[0076] The LS21ΔcydA strain was subjected to a fermentation experiment in a fermenter. In the late fermentation period (after the specific growth rate of net cell biomass μ < 0.01, i.e., after 16 hours of fermentation), stirring was turned off (the aeration volume in the early fermentation period was maintained, and the dissolved oxygen level was controlled at no more than 10%) to synthesize PHA for a total of 48 hours. The LS21 strain was used as a control; a control with normal stirring (800 rpm) was also set up in the late fermentation period. A small amount of sodium valerate was added during the fermentation process to make the product PHA type PHBV.
[0077] Compare co The PHA production of the strain before and after gene knockout under the control of the above different fermentation processes is shown in Table 2.
[0078] Table 2
[0079]
[0080] The results showed that in Halomonas ( Halomonas campaniensis ) LS21 knockout co , higher cell accumulation density can be achieved, and higher PHBV yield can be achieved under anoxic conditions when stirring is stopped in the late fermentation stage.
[0081] Embodiment 3, co Construction and fermentation experiments of gene knockout Halomonas (3)
[0082] Halomonas Halomonas bluephagenesis )WZY254 knockout co Gene, get co The gene knockout strain of Halomonas was named WZY254ΔcydA.
[0083] The WZY254ΔcydA strain was subjected to a fermentation experiment. In the late fermentation period (after the specific growth rate of net cell biomass μ < 0.01, i.e., after 16 hours of fermentation), stirring was turned off (the aeration volume in the early fermentation period was maintained, and the dissolved oxygen level was controlled at no more than 10%) to synthesize PHA for a total of 48 hours. The WZY254 strain was used as a control; a control with normal stirring (800 rpm) was also set up in the late fermentation period. P34HB was obtained by adding butyrolactone during the fermentation process.
[0084] Compare co The PHA production of the strain before and after gene knockout under the control of the above-mentioned different fermentation processes is shown in Table 3.
[0085] Table 3
[0086]
[0087] The results showed that Halomonas ( Halomonas bluephagenesis ) Knockout in WZY254 co , higher P34HB production can be achieved under anoxic conditions when stirring is stopped in the late fermentation stage.
[0088] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or make equivalent replacements for some of the technical features therein. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.
Claims
1. A method for producing PHA, characterized in that: The method comprises: engineering a PHA-producing halomonas ( Halomonas ) performing fermentation culture and collecting PHA in the culture; Wherein, the engineered Halomonas producing PHA cydA Gene inactivation; cydA The amino acid sequence of the gene-encoded protein is the amino acid sequence encoded by the nucleotide sequence shown in SEQ ID NO.1; The fermentation culture includes an early fermentation stage and a late fermentation stage; In the early stage of fermentation, the dissolved oxygen is maintained at not less than 30%, and in the late stage of fermentation, the dissolved oxygen is maintained at not more than 10%.
2. cydA Application of gene inactivation in improving PHA production in Halomonas; The method of increasing the PHA production of Halomonas is to increase the PHA production of Halomonas under anoxic or anaerobic conditions in the late fermentation period; The anoxic or anaerobic condition means that the dissolved oxygen level is not higher than 10%; Said cydA The amino acid sequence of the gene-encoded protein is the amino acid sequence encoded by the nucleotide sequence shown in SEQ ID NO.
1.
3. cydA Application of gene inactivation in breeding of Halomonas suitable for fermentation and production of PHA under anoxic or anaerobic conditions in the late fermentation period; the anoxic or anaerobic conditions are those in which the dissolved oxygen level is not higher than 10%; Said cydA The amino acid sequence of the gene-encoded protein is the amino acid sequence encoded by the nucleotide sequence shown in SEQ ID NO.
1.
4. A method for increasing the PHA production of Halomonas under anoxic or anaerobic conditions in the late fermentation period, characterized in that: The method comprises: cydA Gene inactivation; Said cydA The amino acid sequence of the gene-encoded protein is the amino acid sequence encoded by the nucleotide sequence shown in SEQ ID NO.1; The anoxic or anaerobic condition means that the dissolved oxygen level is no higher than 10%.
Citation Information
Patent Citations
Halomonas strain and application thereof
CN102120973A
Method for producing hydrocarbons for making fuel by using sea water as medium and special strain
CN102925382A
Construction and application of polygene knockout strain of Halomonas sp. TD01
CN102816729A
Microbial gene expression fate community as well as construction method and application thereof
CN113564193A
Recombinant microorganism and application thereof in production of polyhydroxyalkanoate
CN116904384A
